Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays

Journal of Clinical Medicine

doi 10.3390/jcm4101890

Full Text

Abstract

Available in

Date

October 23, 2015

Authors

Makoto Nagahara

Publisher

MDPI AG

Related search

Large-Scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer

Clinical Cancer Research

Cancer Research

English

Potential of Circulating Biomarkers in Liquid Biopsy Diagnostics

Molecular Biology

English

Current Dietary Lipids Recommendations: Pros and Cons

Journal of Nutrition and Health Sciences

English

Circulating microRNA-92a and microRNA-21 as Novel Minimally Invasive Biomarkers for Primary Breast Cancer

Journal of Cancer Research and Clinical Oncology

Cancer Research

English

Pros and Cons

La négociation collective dans le milieu universitaire

English

Correction: Circulating microRNA Signature as Liquid-Biopsy to Monitor Lung Cancer in Low-Dose Computed Tomography Screening

English

JCSE01.05 Biomarkers and Liquid Biopsy for Early Detection of Lung Cancer

Journal of Thoracic Oncology

Respiratory Medicine

English

P2.11-19 MicroRNAs as Liquid Biopsy Biomarkers for Early Detection in Lung Cancer.

Journal of Thoracic Oncology

Respiratory Medicine

English

The TAP Block in Obese Patients: Pros and Cons

Minerva Anestesiologica

English